202 related articles for article (PubMed ID: 21951695)
41. CXCL8 Knockout: A Key to Resisting
Yuan J; Zhao Q; Li J; Wen Y; Wu R; Zhao S; Lang YF; Yan QG; Huang X; Du S; Cao SJ
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791369
[No Abstract] [Full Text] [Related]
42. Modulation of host cell gene expression through activation of STAT transcription factors by Pasteurella multocida toxin.
Orth JH; Aktories K; Kubatzky KF
J Biol Chem; 2007 Feb; 282(5):3050-7. PubMed ID: 17150962
[TBL] [Abstract][Full Text] [Related]
43. Lipid and phase specificity of α-toxin from S. aureus.
Schwiering M; Brack A; Stork R; Hellmann N
Biochim Biophys Acta; 2013 Aug; 1828(8):1962-72. PubMed ID: 23590994
[TBL] [Abstract][Full Text] [Related]
44. YopT domain of the PfhB2 toxin from Pasteurella multocida: protein expression, characterization, crystallization and crystallographic analysis.
Kumar S; Hedrick V; Mattoo S
Acta Crystallogr F Struct Biol Commun; 2018 Mar; 74(Pt 3):128-134. PubMed ID: 29497015
[TBL] [Abstract][Full Text] [Related]
45. Pasteurella multocida toxin - lessons learned from a mitogenic toxin.
Kubatzky KF
Front Immunol; 2022; 13():1058905. PubMed ID: 36591313
[TBL] [Abstract][Full Text] [Related]
46. Action of Pasteurella multocida toxin depends on the helical domain of Galphaq.
Orth JH; Lang S; Aktories K
J Biol Chem; 2004 Aug; 279(33):34150-5. PubMed ID: 15192096
[TBL] [Abstract][Full Text] [Related]
47. Application of intact cell-based NFAT-beta-lactamase reporter assay for Pasteurella multocida toxin-mediated activation of calcium signaling pathway.
Luo S; Ho M; Wilson BA
Toxicon; 2008 Mar; 51(4):597-605. PubMed ID: 18190943
[TBL] [Abstract][Full Text] [Related]
48. Influence of Pasteurella multocida Toxin on the differentiation of dendritic cells into osteoclasts.
Chakraborty S; Kloos B; Roetz N; Schmidt S; Eigenbrod T; Kamitani S; Kubatzky KF
Immunobiology; 2018 Jan; 223(1):142-150. PubMed ID: 29030011
[TBL] [Abstract][Full Text] [Related]
49. [Characteristics and immunogenicity of the N-terminal and C-terminal recombinants of Pasteurella multocida toxin].
Tang X; Wu B; Zhao Z; Deng Y; He H; He Q; Chen H
Wei Sheng Wu Xue Bao; 2008 Feb; 48(2):213-9. PubMed ID: 18438004
[TBL] [Abstract][Full Text] [Related]
50. Ultrastructural localization of the Pasteurella multocida toxin in a toxin-producing strain.
iDali C; Foged NT; Frandsen PL; Nielsen MH; Elling F
J Gen Microbiol; 1991 May; 137(5):1067-71. PubMed ID: 1865180
[TBL] [Abstract][Full Text] [Related]
51. Pasteurella multocida toxin is a potent activator of anti-apoptotic signalling pathways.
Preuss I; Hildebrand D; Orth JH; Aktories K; Kubatzky KF
Cell Microbiol; 2010 Aug; 12(8):1174-85. PubMed ID: 20331638
[TBL] [Abstract][Full Text] [Related]
52. Protective potential of an attenuated Pasteurella multocida, which expresses only the N-terminal truncated fragment of P. multocida toxin.
Seo J; Lee S; Pyo H; Lee J; Kim T
Can J Vet Res; 2010 Jan; 74(1):25-9. PubMed ID: 20357954
[TBL] [Abstract][Full Text] [Related]
53. Immunological roles of Pasteurella multocida toxin (PMT) using a PMT mutant strain.
Kim TJ; Toan NT; Jang EJ; Jung BG; Lee JI; Lee BJ
J Microbiol; 2007 Aug; 45(4):364-6. PubMed ID: 17846592
[TBL] [Abstract][Full Text] [Related]
54. Sphingomyelin functions as a novel receptor for Helicobacter pylori VacA.
Gupta VR; Patel HK; Kostolansky SS; Ballivian RA; Eichberg J; Blanke SR
PLoS Pathog; 2008 May; 4(5):e1000073. PubMed ID: 18497859
[TBL] [Abstract][Full Text] [Related]
55. Pasteurella multocida toxin and Bordetella bronchiseptica dermonecrotizing toxin elicit similar effects on cultured cells by different mechanisms.
Ohnishi T; Horiguchi Y; Masuda M; Sugimoto N; Matsuda M
J Vet Med Sci; 1998 Mar; 60(3):301-5. PubMed ID: 9560776
[TBL] [Abstract][Full Text] [Related]
56. Pasteurella multocida toxin stimulates mitogenesis and cytoskeleton reorganization in Swiss 3T3 fibroblasts.
Dudet LI; Chailler P; Dubreuil JD; Martineau-Doize B
J Cell Physiol; 1996 Jul; 168(1):173-82. PubMed ID: 8647912
[TBL] [Abstract][Full Text] [Related]
57. Bacterial intracellularly active toxins: Membrane localisation of the active domain.
Varela-Chavez C; Blondel A; Popoff MR
Cell Microbiol; 2020 Jul; 22(7):e13213. PubMed ID: 32353188
[TBL] [Abstract][Full Text] [Related]
58. Cellular uptake of Clostridium difficile toxin B. Translocation of the N-terminal catalytic domain into the cytosol of eukaryotic cells.
Pfeifer G; Schirmer J; Leemhuis J; Busch C; Meyer DK; Aktories K; Barth H
J Biol Chem; 2003 Nov; 278(45):44535-41. PubMed ID: 12941936
[TBL] [Abstract][Full Text] [Related]
59. Biological activity of a C-terminal fragment of Pasteurella multocida toxin.
Busch C; Orth J; Djouder N; Aktories K
Infect Immun; 2001 Jun; 69(6):3628-34. PubMed ID: 11349023
[TBL] [Abstract][Full Text] [Related]
60. Intranasal vaccination of New Zealand white rabbits against pasteurellosis, using alginate-encapsulated Pasteurella multocida toxin and potassium thiocyanate extract.
Jarvinen LZ; HogenEsch H; Suckow MA; Bowersock TL
Comp Med; 2000 Jun; 50(3):263-9. PubMed ID: 10894489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
